Revision: Dec. 14, 2021, 4:26 p.m.
SB 335 - AS INTRODUCED
2022 SESSION
22-3083
05/11
SENATE BILL 335
AN ACT relative to collaborative pharmacy practice agreements.
SPONSORS: Sen. Prentiss, Dist 5; Sen. Watters, Dist 4; Sen. Hennessey, Dist 1; Sen. Rosenwald, Dist 13; Sen. Avard, Dist 12; Sen. Carson, Dist 14; Sen. Gannon, Dist 23; Sen. Whitley, Dist 15; Sen. Cavanaugh, Dist 16; Sen. Sherman, Dist 24; Rep. Murphy, Graf. 12; Rep. P. Schmidt, Straf. 19; Rep. Merchant, Sull. 4
COMMITTEE: Health and Human Services
-----------------------------------------------------------------
ANALYSIS
This bill provides that a collaborative pharmacy practice agreement is an agreement between a pharmacist and attending practitioner.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
22-3083
05/11
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Two
AN ACT relative to collaborative pharmacy practice agreements.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Collaborative Pharmacy Practice Agreement. Amend RSA 318:1, XXVII to read as follows:
XXVII. "Collaborative pharmacy practice agreement" means a written and signed specific agreement between a pharmacist[,] and an attending practitioner, [and the patient or patient's authorized representative who has granted his or her informed consent,] that provides for collaborative pharmacy practice for the purpose of medication therapy management for the patient.
2 Effective Date. This act shall take effect 60 days after its passage.